Opiate abuse, innate immunity, and bacterial infectious diseases

被引:0
作者
Jinghua Wang
Roderick A. Barke
Jing Ma
Richard Charboneau
Sabita Roy
机构
[1] University of Minnesota,Division of Basic and Translational Research, Department of Surgery
[2] Veterans Affairs Medical Center,Department of Surgery
[3] Jilin University Norman Bethune Medical College,Department of Immunology
[4] University of Minnesota,Department of Pharmacology
来源
Archivum Immunologiae et Therapiae Experimentalis | 2008年 / 56卷
关键词
opiate; morphine; innate immunity; macrophages; neutrophils; dentritic cells; NK cells; γδ T lymphocytes; cytokines; bacterial infection;
D O I
暂无
中图分类号
学科分类号
摘要
The first line of defense against invading bacteria is provided by the innate immune system. Morphine and other opiates can immediately disrupt the body’s first line of defense against harmful external bacteria. Opiate, for example morphine, abuse degrades physical and physiologic barriers, and modulates phagocytic cells (macrophages, neutrophils) and, nonspecific cytotoxic T cells (γδ T), natural killer cells, and dendritic cells, that are functionally important for carrying out a rapid immune reaction to invading pathogens. In vitro studies with innate immune cells from experimental animals and humans and in vivo studies with animal models have shown that opiate abuse impairs innate immunity and is responsible for increased susceptibility to bacterial infection. However, to better understand the complex interactions between opiates, innate immunity, and bacterial infection and develop novel approaches to treat and even prevent bacterial infection in the opiate-abuse population, there is an urgent need to fill the numerous gaps in our understanding of the cellular and molecular mechanisms by which opiate abuse increases susceptibility to bacterial infection.
引用
收藏
页码:299 / 309
页数:10
相关论文
共 50 条
  • [1] Opiate abuse, innate immunity, and bacterial infectious diseases
    Wang, Jinghua
    Barke, Roderick A.
    Ma, Jing
    Charboneau, Richard
    Roy, Sabita
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2008, 56 (05) : 299 - 309
  • [2] Antimicrobial peptides in the innate immunity of infectious diseases.
    Rivas-Santiago, B
    Sada, E
    Hernández-Pando, R
    Tsutsumi, V
    SALUD PUBLICA DE MEXICO, 2006, 48 (01): : 62 - 71
  • [3] Toll-like receptors in innate immunity and infectious diseases
    Wu M.-H.
    Zhang P.
    Huang X.
    Frontiers of Medicine in China, 2010, 4 (4): : 385 - 393
  • [4] Role of stomata in plant innate immunity and foliar bacterial diseases
    Melotto, Maeli
    Underwood, William
    He, Sheng Yang
    ANNUAL REVIEW OF PHYTOPATHOLOGY, 2008, 46 : 101 - 122
  • [5] Role of Innate Trained Immunity in Diseases
    Cheng, Chuang
    Wang, Yue-Qing
    Mu, Xiao-Qin
    Zheng, Xi
    He, Jing
    Wang, Jun
    Tan, Chao
    Liu, Xiao-Wen
    Zou, Li-Li
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2025, 52 (01) : 119 - 132
  • [6] Do pathogen exposure and innate immunity cause brain diseases?
    Simard, AR
    Rivest, S
    NEUROLOGICAL RESEARCH, 2005, 27 (07) : 717 - 725
  • [7] Autophagy and bacterial infectious diseases
    Yuk, Jae-Min
    Yoshimori, Tamotsu
    Jo, Eun-Kyeong
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2012, 44 (02) : 99 - 108
  • [8] Editorial: Innate immunity in vasculitis
    De Souza, Alexandre Wagner Silva
    Ooi, Joshua Daniel
    Misra, Durga Prasanna
    Zhong, Yong
    Brown, Kelly L.
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [9] Cancer Immunity: Lessons From Infectious Diseases
    Trinchieri, Giorgio
    JOURNAL OF INFECTIOUS DISEASES, 2015, 212 : S67 - S73
  • [10] Innate lymphoid cells and infectious diseases
    Yuan, Ting
    Zhou, Qianhui
    Tian, Yuqiu
    Ou, Yangjing
    Long, Yunzhu
    Tan, Yingzheng
    INNATE IMMUNITY, 2024, 30 (6-8) : 120 - 135